Work

Synthesis and Biological Evaluation of a Novel 177 Lu-DOTA-[Gly 3 -Cyclized(Dap 4 , d -Phe 7 , Asp 10 )-Arg 11 ]α-MSH 3–13 Analogue for Melanocortin-1 Receptor-Positive Tumor Targeting